Topline Capital Management, LLC

Topline Capital sells 88,645 shares in 3 transactions for $1,012,297.15; reduces stake 11.4% at $11.42 blended avg near 52-week high of $11.49

Topline Capital Management, LLC executed 3 separate sales totaling 88,645 shares for $1,012,297.15 between June 26–30, 2025, reducing holdings by 11.4% from 779,901 to 691,256 shares. The blended average price of $11.42 places the sales within 0.6% of the current price of $11.49, which sits at the 52-week high. Notably, the stock has appreciated 34.7% over the past 30 days and 99.8% over 90 days, creating a context where the insider is liquidating a material portion at elevated valuation. Across Topline's cross-ticker track record, prior sells have demonstrated a 60.00% well-timed rate (measuring instances where the stock fell post-sale), though this represents only 6 prior sells; the pattern warrants monitoring as the company trades at a P/E of 16.18 and has posted recent quarterly revenue of $10,730,000.00 with net income of $1,768,000.00.

Topline Capital Management sold 959,180 shares (15.1% of holdings) in 3 transactions Dec 27–31 for blended avg $10.50, reducing stake to 5.38M shares

Topline Capital Management executed three separate sales totaling 959,180 shares on 2024-12-27, 2024-12-30, and 2024-12-31, ranging from $10.44 to $10.54 per share and totaling $10,071,696.10, reducing its position by 15.1% from 6.34M to 5.38M shares. The sales occurred near the 52-week high of $13.28 but above the current price of $10.64, narrowing the margin by 1.4% from transaction close. Green Dot's fundamentals show recent strain: the latest quarter reported $409.7M revenue with a net loss of $7.8M, and across Topline's prior four GDOT transactions (two each in September and November 2024), buy-side timing outcomes have been consistently negative, with the September trades showing 90-day declines of −12.9% and −14.7%. The timing of this multi-day liquidation alongside weakening operating performance warrants investor attention to whether this reflects a material reassessment of the company's near-term prospects.

Topline Capital Management sold 479,105 shares of PAYS across 3 trades (Dec 27–31) for $1,525,503.87 at avg $3.18; stock now $3.02, down 44.9% from 52-week high.

Topline Capital Management executed 3 separate sales totaling 479,105 shares for $1,525,503.87 between December 27 and December 31, reducing its stake in Paysign from 6,090,233 shares to 5,611,128 shares (a 7.9% reduction). The blended average sale price was $3.18; the stock currently trades at $3.02, down 44.9% from its 52-week high of $5.48 and down 10.9% over the prior 30 days. The insider's cross-ticker track record shows prior sales averaging a 90-day return of +5.0% (a 41.67% win rate), indicating those past sales occurred before subsequent stock appreciation—a pattern of poorly-timed exits. Against this backdrop of negative price momentum and the insider's historical difficulty with sale timing, the scale and recency of this position reduction warrant investor attention to whether market conditions or company fundamentals have shifted.

Topline Capital bought 178,302 shares at blended avg $10.89 across 2 separate purchases on GDOT

Topline Capital Management, LLC purchased 178,302 shares in two tranches on November 8–9, 2024, at a blended average price of $10.89, increasing holdings by 2.9% to 6,335,967 shares and committing $1,941,124.50. The current stock price of $11.39 sits -14.2% from its 52-week high and has gained only +0.4% over the past 30 days despite the insider's entry, while the company posted negative net income of $-7,840,000.00 in the latest quarter against revenue of $409,743,000.00. Notably, Topline's two prior purchases at GDOT on September 23–24, 2024, both underperformed significantly within 30 days (-6.6% and -3.1% respectively), establishing a pattern of poor near-term execution at this ticker despite a cross-ticker track record showing a 58.33% 90-day win rate on prior buys.

Topline Capital purchases 461,777 shares (461.8K) in two tranches totaling $5,275,974.35 at avg $11.43, expanding stake to 5,251,145 (5.25M shares).

Topline Capital, a significant shareholder, deployed $5,275,974.35 across 2 purchases totaling 461,777 shares (461.8K shares) at a blended average price of $11.43, increasing its stake by 9.6% from 4,789,368 shares to 5,251,145 shares (5.25M shares). The purchases occurred on 2024-10-21 and 2024-10-22, a period when NRDS traded -35.2% from its 52-week high and -14.0% over the prior 30 days, after a -30.8% decline over 90 days. The company reported revenue of $150,600,000.00 ($150.6M) in its latest quarter but remains unprofitable with net income of $-9,400,000.00 ($-9.4M) for the most recent full fiscal year, though annual revenue growth stands at +11.2%. Topline's cross-ticker track record shows 20 prior buys with an average 90-day return of +18.4% and a 64.29% win rate, providing context for its capital deployment patterns across multiple holdings.

Topline Capital bought 198,914 shares ($2.4M) at $11.98 avg; stock down -20.9% from high, net income negative

Topline Capital Management completed 2 separate purchases totaling 198,914 shares for $2,383,845.20, executed at an average price of $11.98 on 2024-09-23 and 2024-09-24. The purchases increased the insider's position by 3.3% to 6,157,665 shares. The stock is currently priced at $11.02, down 20.9% from its 52-week high of $13.93, while the company reported a latest quarterly net income of $-28,715,000.00. The insider's cross-ticker track record shows 20 prior buys with an average 90-day return of +21.6% and a 90-day win rate of 68.75%, providing context for purchasing discipline across their portfolio, though same-ticker historical performance at GREEN DOT is not available for direct comparison.

Topline Capital bought 969,631 shares of CGNT for $6.1M at $6.31; holdings rose 12.0% to 9.02M shares

Topline Capital Management, LLC executed two separate purchases totaling 969,631 shares for $6,114,211.21 at a blended average price of $6.31, adding 12.0% to its position. The stock has declined 25.0% from its 52-week high and 13.0% over the past 30 days, placing the purchase in a period of downward price pressure. The insider's cross-ticker track record shows consistent success with 20 prior buys averaging 23.2% gains at 30 days and 24.2% gains at 90 days with a 68.75% win rate, establishing a pattern of disciplined accumulation across multiple securities. This filing documents a material engagement at current market levels, though forward-looking interpretation of intent must remain speculative absent additional context.

Topline Capital bought 23,940 ISDR shares across 2 transactions at avg $9.67; stock now $10.73, up 17.1% in 30d

Topline Capital Management made 2 separate purchases totaling 23,940 shares for $231,473.54, raising holdings from 685.3K to 709.3K shares (+3.5%). The buys occurred at $9.65 (19,826 shares) and $9.76 (4,114 shares) on Aug 27-28, with current price at $10.73, representing a gain on the transactions. At the same-ticker level, Topline's prior 5 ISDR purchases show a mixed record: 2 recent buys (June) show 30-day gains of +10.9% and +11.4%, while 3 earlier buys (May) produced 30-day losses of -15.5%, -16.8%, and -9.6%. The cross-ticker track record (20 prior buys with 72.22% 90-day win rate and avg 90d return +28.8%) does not apply directly to timing accuracy at ISDR; only 1 of 5 measurable same-ticker buys achieved positive 90-day outcomes. The company shows revenue of $7.7M and net income of $7.0K (latest quarter) with strong annual growth at +42.0%, but elevated valuation at P/E 53.65 against a market cap of $41.1M.

Topline Capital Management buys 27,213 shares in ISDR; position up 4.1%; stock down 17.7% in 30 days, 39.3% in 90 days.

Topline Capital Management executed 2 separate purchases totaling 27,213 shares for $212,935.47, acquiring at a blended average price of $7.82 on 2024-06-26 and 2024-06-27. The current price stands at $7.84, approximately flat with the transaction prices. However, the broader price context is deteriorating: the stock is down 17.7% over 30 days and down 39.3% over 90 days, trading 65.5% below its 52-week high of $22.72. At the same ticker (ISDR), this insider's 5 prior buys have all shown negative 30-day returns (ranging from -5.2% to -16.8%), with no yet-measurable 90-day outcomes. While the insider's cross-ticker track record shows a 93.33% win rate on buys with average 90-day returns of +42.6%, that performance has not translated to ISDR, where recent pattern suggests challenged timing or unfavorable stock-specific fundamentals.